Innate immune cells induce hemorrhage in tumors during thrombocytopenia.
Platelets are crucial regulators of tumor vascular homeostasis and continuously prevent tumor hemorrhage through secretion of their granules. However, the reason for tumor bleeding in the absence of platelets remains unknown. Tumors are associated with inflammation, a cause of hemorrhage in thrombocytopenia. Here, we investigated the role of the inflamed tumor microenvironment in the induction of tumor vessel injury in thrombocytopenic mice. Using s.c. injections of vascular endothelial growth factor or tumor necrosis factor-alpha combined with depletion of neutrophils, we demonstrate that enhancing the opening of endothelial cell junctions was not sufficient to cause bleeding in the absence of platelets; instead, induction of tissue hemorrhage in thrombocytopenia required recruitment of leukocytes. Immunohistology revealed that thrombocytopenia-induced tumor hemorrhage occurs at sites of macrophage and neutrophil accumulation. Mice deficient in beta2 or beta3 integrins, which have decreased neutrophil and/or macrophage infiltration in their tumor stroma, were protected from thrombocytopenia-induced tumor hemorrhage, indicating that, in the absence of platelets, stroma-infiltrating leukocytes induced tumor vessel injury. This injury was independent of reactive oxygen species generation and of complement activation, as suggested by the persistence of tumor hemorrhage in C3- and nicotinamide adenine dinucleotide phosphate oxidase-deficient thrombocytopenic mice. Our results show that platelets counteract tumor-associated inflammation and that the absence of this platelet function elicits vascular injuries by tumor-infiltrating innate immune cells.
Ho-Tin-Noé
Benoit
B
Immune Disease Institute, Boston, MA 02115, USA.
Carbo
Carla
C
Demers
Mélanie
M
Cifuni
Stephen M
SM
Goerge
Tobias
T
Wagner
Denisa D
DD
D000818:Animals; D002199:Capillary Permeability; D002452:Cell Count; D016923:Cell Death; D045744:Cell Line, Tumor; D002465:Cell Movement; D003167:Complement Activation / Q000276:immunology; D005260:Female; D006470:Hemorrhage / Q000150:complications* / Q000276:immunology* / Q000473:pathology; D007113:Immunity, Innate / Q000276:immunology*; D016023:Integrins / Q000378:metabolism; D008264:Macrophages / Q000473:pathology; D051379:Mice; D009369:Neoplasms / Q000098:blood supply / Q000150:complications* / Q000473:pathology; D009504:Neutrophils / Q000473:pathology; D017382:Reactive Oxygen Species / Q000378:metabolism; D012867:Skin / Q000098:blood supply / Q000473:pathology; D013921:Thrombocytopenia / Q000150:complications* / Q000473:pathology
D016023:Integrins; D017382:Reactive Oxygen Species